We are live on
!
Find out more
X
Xponance Portfolio holdings
AUM
$16.3B
1-Year Est. Return
44.61%
This Fund
S&P 500
This Quarter
Est. Return
-15.67%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$4.98B
AUM Growth
-$1.04B
(-17%)
Cap. Flow
+$50.1M
Cap. Flow
% of AUM
1.01%
Top 10 Holdings %
Top 10 Hldgs %
30.66%
Holding
1,260
New
93
Increased
866
Reduced
230
Closed
68
Avg Time Held
6.6
quarters
Top 10 Avg Time Held
6.3
quarters
Top 20 Avg Time Held
4.9
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$40.1M |
| 2 |
Procter & Gamble
PG
|
+$19.2M |
| 3 |
Merck
MRK
|
+$12.2M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$10.3M |
| 5 |
IBM
IBM
|
+$9.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$37.9M |
| 2 |
Apple
AAPL
|
+$19.7M |
| 3 |
Microsoft
MSFT
|
+$14.9M |
| 4 |
Home Depot
HD
|
+$14.7M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$8.67M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.34% |
| 2 | Healthcare | 13.95% |
| 3 | Consumer Discretionary | 12.19% |
| 4 | Financials | 10.87% |
| 5 | Communication Services | 8.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1176
Diversified Healthcare Trust
DHC
$1.85B
| $23K | ﹤0.01% |
12,845
+1,553
| +14% | +$3.55K |
2021 Q2
4 quarters
|
|
1177
Bionano Genomics
BNGO
$15.8M
| $22K | ﹤0.01% |
26
+3
| +13% | +$3.09K |
2021 Q2
4 quarters
|
|
1178
Nordic American Tanker
NAT
$1.86B
| $22K | ﹤0.01% |
+10,314
| New | +$24.6K |
2022 Q2
0 quarters
|
|
1179
Clear Channel Outdoor Holdings
CCO
$1.24B
| $21K | ﹤0.01% |
19,769
+2,526
| +15% | +$5.29K |
2021 Q2
4 quarters
|
|
1180
Inovio Pharmaceuticals
INO
$114M
| $21K | ﹤0.01% |
+989
| New | +$27.9K |
2022 Q2
0 quarters
|
|
1181
ADMA Biologics
ADMA
$2.28B
| $20K | ﹤0.01% |
+10,082
| New | +$19.8K |
2022 Q2
0 quarters
|
|
1182
Firy Inc
FIRY
$206M
| $20K | ﹤0.01% |
822
-1,021
| -55% | -$39.8K |
2021 Q2
4 quarters
|
|
1183
DELISTED
NeueHealth
NEUE
| $19K | ﹤0.01% |
129
-24
| -16% | -$3.49K |
2022 Q1
1 quarter
|
|
|
AMRS
1184
DELISTED
Amyris Inc.
AMRS
| $19K | ﹤0.01% |
+10,534
| New | +$31K |
2022 Q2
0 quarters
|
|
1185
DELISTED
Core Scientific, Inc. Common Stock
CORZ
| $18K | ﹤0.01% |
+11,780
| New | +$54.1K |
2022 Q2
0 quarters
|
|
1186
Hippo Holdings
HIPO
$905M
| $12K | ﹤0.01% |
+553
| New | +$20.4K |
2022 Q2
0 quarters
|
|
1187
Ur-Energy
URG
$367M
| $12K | ﹤0.01% |
+11,444
| New | +$15.3K |
2022 Q2
0 quarters
|
|
|
VLDR
1188
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
| $10K | ﹤0.01% |
+10,470
| New | +$18.1K |
2022 Q2
0 quarters
|
|
1189
VistaGen Therapeutics
VTGN
$10.1M
| $9K | ﹤0.01% |
+352
| New | +$12.4K |
2022 Q2
0 quarters
|
|
1190
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $8K | ﹤0.01% |
+345
| New | +$11.7K |
2022 Q2
0 quarters
|
|
|
ENDP
1191
DELISTED
Endo International plc
ENDP
| $6K | ﹤0.01% |
12,613
+1,730
| +16% | +$2.2K |
2021 Q2
4 quarters
|
|
1192
Adaptive Biotechnologies
ADPT
$4.08B
| – | – |
-11,412
| Closed | -$158K | – |
|
1193
AMC Entertainment Holdings
AMC
$2.68B
| – | – |
-2,504
| Closed | -$617K | – |
|
1194
Digital Turbine
APPS
$1.29B
| – | – |
-13,138
| Closed | -$576K | – |
|
1195
Optimum Communications Inc
OPTU
$370M
| – | – |
-17,258
| Closed | -$215K | – |
|
1196
Brookfield Renewable
BEPC
$5.44B
| – | – |
-4,856
| Closed | -$213K | – |
|
1197
Beyond Meat
BYND
$126M
| – | – |
-188
| Closed | -$273K | – |
|
1198
CarGurus
CARG
$2.53B
| – | – |
-5,051
| Closed | -$214K | – |
|
1199
Chegg
CHGG
$78.9M
| – | – |
-12,453
| Closed | -$452K | – |
|
1200
CONMED
CNMD
$1.36B
| – | – |
-1,844
| Closed | -$273K | – |
|
Similar funds
PCM
LPC
MFG
PAM
BS
BBVA
NMO
PAS
Xponance's Q2 2022 Portfolio in Review
As of Q2 2022, Xponance held 1,260 positions worth $4.98B, down 17% from $6.01B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Xponance's Q2 2022 filing shows 93 new, 866 increased, 230 reduced and 68 closed positions. Its largest new stake was Warner Bros: 370,598 shares worth $4.97M. The largest sale was Meta Platforms (Facebook), an estimated $37.9M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Xponance's largest Q2 2022 buy was Warner Bros: 370,598 shares worth $4.97M.
- Xponance added most to UnitedHealth in Q2 2022, an estimated $40.1M increase.
- Xponance's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $37.9M.
- Xponance fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $2.36M.
- Xponance's ten largest holdings make up 31% of its $4.98B portfolio in Q2 2022.
- Xponance opened 93 new positions and closed 68 in Q2 2022.
- Xponance's portfolio value fell 17% quarter-over-quarter to $4.98B.
Based on Xponance's 13F filing for Q2 2022, filed 2 Aug 2022.